Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight over 6 to 12 months, is a common yet challenging clinical presentation. The etiology can range from benign to life-threatening conditions, making a structured approach to evaluation crucial.
The first step involves a comprehensive history and physical examination. This should focus on dietary history, medication use, psychosocial factors, and symptoms suggestive of systemic diseases. Particular attention should be paid to signs of malignancy, endocrine disorders, gastrointestinal diseases, and psychiatric illnesses.
If the initial assessment is inconclusive, routine laboratory tests including complete blood count, metabolic panel, liver function tests, thyroid function tests, and inflammatory markers should be considered. Imaging studies such as chest X-ray or abdominal ultrasound may be indicated based on the clinical suspicion.
In cases where routine investigations fail to identify the cause, more specialized testing may be warranted. Endoscopy, CT or MRI scans, and specific hormonal assays may be considered based on the patient's symptoms and risk factors.
Management of UWL should be directed towards the underlying cause. In cases where no specific cause can be identified, symptomatic and supportive treatment should be provided. Nutritional support and regular follow-up are essential in all cases.
In conclusion, UWL is a complex clinical issue that requires a systematic and comprehensive approach. While it can be a marker of serious illness, a significant proportion of cases remain unexplained even after extensive evaluation. This underscores the importance of a thorough initial assessment, judicious use of diagnostic tests, and a patient-centered approach to management.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation